TRANSGENE BIOTEK LTD.
No fund holds it No Indian mutual fund has disclosed this company in any monthly portfolio this build holds (2012-09 onwards). It is here because it trades on the BSE — the price history below is real; the ownership sections have nothing to report. Most companies that quote only on the BSE are held by no fund at all; that is a fact about the company’s size and liquidity, not a gap in this data.
Who holds it
no fund has disclosed this company, so there is nothing to list
| Fund | Weight | Since | Entry close | Now vs entry | 3-mo change | Action |
|---|---|---|---|---|---|---|
| No fund has disclosed holding this company. | ||||||
A holder disclosed the stock in the latest month or the one before; an exit is listed for three disclosures. Entry close is the split- and bonus-adjusted close at the end of the month the fund first disclosed the position; “now vs entry” is price only, not the fund's return on the position. Estimated cost basis per fund from monthly unit deltas is not computed in this build.
Three-month flow
not computed
net change in Σ fund weight over the last three disclosures (percentage points summed across funds) · 0 added or entered, 0 trimmed or exited
Crowding
0 funds hold it, at an average weight of — each (0.0% summed across holders). Days-to-exit needs the aggregate MF share count and average volume; not computed for this stock.
Who moved last quarter
the three-month flow, fund by fund — largest move first
One year
daily BSE close, unadjusted — the exchange publishes nothing to adjust from
Prices are the BSE close. This series is not adjusted for splits or bonuses. It cannot be: the BSE never adjusts its published previous close — measured, it matched the previous session’s close on every one of 811,633 consecutive pairs in 2026 — and the NSE’s corporate-action list is keyed by NSE symbol, which a company that never listed there does not have. So a split reads here as a one-day fall. Saying that is better than implying an adjustment that did not happen.